The Effect of Grocery Support Dose on Food Insecurity and Disease Control Among Covered California Members With Diabetes or Hypertension

March 12, 2026 updated by: University of California, San Francisco
This continuation study is a pragmatic randomized controlled trial (RCT) of Covered California's Grocery Support Program among low-income participants with diabetes or hypertension. This pragmatic RCT will compare the efficacy of providing different benefit amounts ($80 vs. $120) via a monthly food card benefit for households where at least one adult has diabetes and/or hypertension and incomes below 250% of the federal poverty level (FPL).

Study Overview

Detailed Description

In 2024, Covered California initiated multiple Population Health Investments (PopHIs) based on funds collected by participating plans if they failed to meet a set of quality benchmarks related to diabetes control, blood pressure control, colorectal cancer screening, and childhood immunizations. One priority area for the PopHIs was food insecurity among patients who manage diabetes and/or hypertension. Food insecurity, defined by the US Department of Agriculture (USDA) as a "lack of access to enough food for an active, healthy life" effects 18% of newly enrolled Covered California members. Food insecurity is more pronounced and is associated with poor clinical outcomes and more avoidable and costly healthcare utilization among individuals who manage diabetes and/or hypertension. In 2025, Covered California initiated the first year of the food insecurity PopHI comparing the impact of an $80 monthly grocery support cash card for 12-months versus a one-time payment at the end of 12-months among a low-income cohort with food insecurity and a chronic condition. Building off year one learnings, Covered California tailored their program design and benefit amount based on findings. While produce prescription and grocery support programs have been shown to reduce food insecurity and improve diet quality, key implementation questions most importantly the impact of varying doses, remain to be understood. The goal of the proposed research is to evaluate the impact of two different doses of a 12-month grocery support program on participant food insecurity and health outcomes among a cohort of individuals with diabetes and/or hypertension. Participants were invited to enroll in the program if they were active members of Covered California at the time of enrollment and had a documented diabetes and/or hypertension diagnosis and an income at or below 250% of the FPL. Participants were randomly assigned to receive either an $80 or $120 reusable semi-restricted cash card re-loaded monthly for one year (payments in both arms adjusted based on household size). Retailers are restricted to food retailers, which includes retailers that do sell non-food goods. The study has four main data sources: survey data from surveys repeated at baseline and 12-months; cash card spending data; qualitative participant interview data, and administrative claims data.

Study Type

Interventional

Enrollment (Estimated)

4450

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Laura Gottlieb, MD, MPH
  • Phone Number: 415-509-8976
  • Email: siren@ucsf.edu

Study Contact Backup

Study Locations

    • California
      • San Francisco, California, United States, 94107
        • SIREN 675 18th Street
        • Contact:
          • Laura Gottlieb, MD, MPH
          • Phone Number: 415-509-8976
          • Email: siren@ucsf.edu
        • Sub-Investigator:
          • Emma Tucher, PhD
        • Principal Investigator:
          • Laura M Gottlieb, MD, MPH
        • Principal Investigator:
          • Danielle Hessler Jones, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Active Covered California member
  • Adult >= 18 years of age
  • Has a diabetes and or hypertension diagnosis identifiable in Covered California's administrative claims
  • Income <250% FPL

Exclusion Criteria:

  • No longer a Covered California member
  • $0 spending in year 1 grocery support program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Monthly $80 grocery support program
The intervention entails the provision of an $80 monthly payment (adjusted by household size) in the form of a re-loadable cash card to be used at food retailers including food retailers who sell non-food item.
$80 monthly (adjusted by household size), re-loadable cash card for use at food retailers
Active Comparator: Monthly $120 grocery support program
The active comparator entails the provision of a $120 monthly payment (adjusted by household size) in the form of a re-loadable cash card to be used at food retailers including food retailers who sell non-food item.
$120 monthly (adjusted by household size), re-loadable cash card for use at food retailers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food insecurity status
Time Frame: Baseline, 12 months
Measured by 2-item Hunger Vital Sign, a validated tool to assess food insecurity. Higher scores indicate greater food insecurity.
Baseline, 12 months
Change in HbA1c
Time Frame: Baseline, 12 months
Change in self-reported HbA1c from baseline by study arm.
Baseline, 12 months
Change in frequency of experiences of hypoglycemia
Time Frame: Baseline, 12 months
Measured using the change in self-reported frequency per week that a participant experiences hypoglycemia.
Baseline, 12 months
Change in blood pressure
Time Frame: Baseline, 12 months
Change in self-reported systolic and diastolic blood pressure from baseline by study arm.
Baseline, 12 months
Change in diabetes and/or hypertension distress
Time Frame: Baseline, 12 months
The change is measured using an adapted 10-item version of the validated 17-item Diabetes and Hypertension Distress Scale, where each item ranges from 1-5, mean score ranges from 1-5, and total score is 10-50 with higher scores indicating greater diabetes- and hypertension-related distress.
Baseline, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrition security
Time Frame: Baseline, 12 months
Measured using the one-item response allowing calculation of the proportion of participants that report difficulty getting and eating healthy foods.
Baseline, 12 months
Diet quality
Time Frame: Baseline, 12 months
Measured using the self-reported number of servings of vegetables or number of days where higher fat foods were consumed during the past 7 days, by study arm.
Baseline, 12 months
Acute health care utilization
Time Frame: 2 years before study start until 12 months after
Proportion of participants that used the ED or had a treat and release ED or observation room visit and number of visits by study arm.
2 years before study start until 12 months after
Hospital admissions
Time Frame: 2 years before study start until 12 months after
Proportion of participants who were hospitalized at least once and count of total hospitalizations from baseline to 12 months by study arm.
2 years before study start until 12 months after
Hospital readmissions
Time Frame: 2 years before study start until 13 months after
Proportion of participants who were re-hospitalized within 30-days of the index hospitalization by study arm.
2 years before study start until 13 months after
Outpatient visits
Time Frame: 2 years before study start until 12 months after
Number of primary care provider, specialist, mental health, and addiction medicine visits across the 12 month study period by study arm.
2 years before study start until 12 months after
Self-rated physical and mental health
Time Frame: Baseline, 12 months
Measured as the change in self-rated overall, physical, and mental health reported on a 0 to 5-response (excellent to poor) scale by study arm. Higher score corresponds to better self-rated health.
Baseline, 12 months
Self-reported medication adherence
Time Frame: Baseline, 12 months
Measured as an affirmative response to cost-based medication nonadherence and the change in a single-item question asking patients how many days (out of 7) they missed taking one of their medications. Changes in the number of days reported from baseline by study arm.
Baseline, 12 months
Medication adherence
Time Frame: 2 years before study start until 12 months after
Measured using medical claims data and calculated based on daily supply.
2 years before study start until 12 months after
Medication count
Time Frame: 2 years before study start until 12 months after
Measured using the survey and medical claims as the total number of medications that the participant had at baseline and across the 12-month study period.
2 years before study start until 12 months after
Cost-based changes to primary care or medication use
Time Frame: Baseline, 12 months
Measured using a 5-response question (never to often) to delays to medical care because of cost and a binary (yes/no) response to a question about cost-related medication nonadherence.
Baseline, 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low food security
Time Frame: Baseline, 12 months
Measured as the change in the proportion of participants with low food security. Low food security will be defined as one or more item answered with "Often true" in the Hunger Vital Sign. Change in proportion of participants with low food security, from baseline to 12 months.
Baseline, 12 months
Nutrition security
Time Frame: Baseline, 12 months
Measured using the 14-response options providing reasons why respondents have difficulty eating or not eating healthy foods.
Baseline, 12 months
Self-reported utilization
Time Frame: Baseline, 12 months
Measured based on the change in self-reported hospitalizations, doctors visits, and ED visits within the past 12 months measured as continuous outcome between 0 and 100 or more.
Baseline, 12 months
Other social risks
Time Frame: Baseline, 12 months
Measured using the change in severity or presence of other social risks assessed using validated survey items for housing insecurity, transportation barriers, and financial strain.
Baseline, 12 months
Trade-offs
Time Frame: Baseline, 12 months
Measured using the proportion of participants who report sometimes or often making trade offs between paying for food and paying for medications or medical care, utilities, rent or mortgage, transportation, and education.
Baseline, 12 months
Self-rated health
Time Frame: Baseline, 12 months
Measured using the validated 10-item measure (PROMIS-10) to assess self-rated health, quality of life, mental and physical health, social satisfaction, ability to carry out roles, ability to carry out everyday physical activities, experiences of fatigue, frequency of emotional problems, and average pain. Analysis will assess change in overall measure by study arm.
Baseline, 12 months
Perceived stress
Time Frame: Baseline, 12 months
Measured using changes in self-report based on a validated, 10-item perceived stress scale.
Baseline, 12 months
Self-efficacy
Time Frame: Baseline, 12 months
Measured using changes in participant responses across the 9-item validated self-efficacy scale.
Baseline, 12 months
Chronic disease self-efficacy
Time Frame: Baseline, 12 months
Measured using changes in participant responses across the validated, two-item chronic disease self-efficacy scale.
Baseline, 12 months
Utilization characteristics
Time Frame: 2 years before study start until 12 months after.
Measured using claims data to analyze utilization characteristics e.g., length of stay (total days, average number of days per stay), days until next admit, and total cost of admissions across the 12 month study period.
2 years before study start until 12 months after.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Laura M Gottlieb, MD, MPH, University of California, San Francisco
  • Principal Investigator: Danielle Hessler Jones, PhD, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 10, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

March 10, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data is not available without a data use agreement with Covered California to protect patient health information in alignment with secure data storage and research ethical practices in alignment with our IRB protocol.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on $80 Grocery Support Monthly Program

Subscribe